Navigation Links
Robert S. Langer, Sc.D., joins eLux Medical Scientific Advisory Board

SAN DIEGO, Aug. 12, 2014 /PRNewswire-iReach/ -- eLux Medical, Inc., developer of NanoLipo™, a novel nanomedicine approach to liposuction, is pleased to announce that Professor Robert S. Langer, Sc.D., has joined its Scientific Advisory Board. Dr. Langer is the David H. Koch Institute Professor at the Massachusetts Institute of Technology. Dr. Langer has written over 1,250 articles and has over 1,060 patents worldwide, many of which have been licensed or sublicensed to over 250 pharmaceutical, chemical, biotechnology and medical device companies. (a full biography for Dr. Langer is available at

Dr. Langer stated: "NanoLipo is a very novel approach to making liposuction a more consistent and successful procedure for both physicians and their patients. I am very pleased to be asked to contribute to its development."

Dr. Langer will advise eLux as it prepares for the clinical trial phase of the development of NanoLipo, a proprietary injectable solution of gold nanoparticles which is projected to transform the performance and results of liposuction, the number one cosmetic surgery worldwide.

eLux co-Founder and Chief Technology Officer, Professor Adah Almutairi, Ph.D., said: "the pre-clinical results of NanoLipo have been very encouraging. As we move into clinical trials, we are honored to have Dr. Langer join our Scientific Advisory Board. His extensive experience and advice will be invaluable throughout our technical development and commercialization process."

About eLux Medical, Inc.

San Diego based eLux Medical is a development stage company, which has spun out of the University of California San Diego (UCSD) Center of Excellence in Nanomedicine, of which Professor Adah Almutairi is the Director. eLux Medical has an exclusive worldwide license on the intellectual property related to NanoLipo from UCSD.

About Forward-Looking Statements

The Company cautions you that the statements included in the press release that are not a description of historical facts are forward-looking statements. These include statements regarding the potential clinical benefits of NanoLipo and the commercial prospects of eLux Medical, Inc. NanoLipo is an investigational device and is not approved for sale in the USA or any other country.


John R. Lyon, CEO




Chris Smith


Media Contact: Chris Smith, eLux Medical Inc,, 858-220-6939,

News distributed by PR Newswire iReach:

SOURCE eLux Medical Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. TB Alliance Names Elana Robertson Senior Vice President, Market Access
2. CFO Journal, part of the Wall Street Journal, addresses business challenges of cannabis industry in the article "Pot Industry Puts on a Tie" referencing Cannabis Science, Inc. (CBIS) Chief Financial Officer, Robert Kane
3. Varian Imaging Components President Robert Kluge Announces Plans to Retire; Varian CEO Dow Wilson Names Sunny Sanyal as Kluges Successor
4. Trevena Appoints Roberto Cuca as Senior Vice President & Chief Financial Officer
5. Regeneron Announces Appointment of Robert E. Landry as Senior Vice President, Finance and Chief Financial Officer
6. PAREXEL International To Present At Robert Baird Healthcare Conference And Raymond James North American Equities Conference
7. Medical Laser Expert Robert E. Grove, PhD Appointed To Ellman International Board of Directors
8. BioLife Solutions Announces the Addition of Robert Preti, Ph.D. to its Scientific Advisory Board
9. Dr. Robert Bernstein in NY Magazines Best Doctors Issue for 14th Consecutive Year
10. UBM Canon and MD+DI, the Global MedTech Authorities, Announce Dr. Robert Langer as the 2013 MDEA Lifetime Achievement Award Recipient
11. NxStage Names Robert G. Funari Chairman Of The Board
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... European Therapeutic Drug Monitoring (TDM) Market: ... Intelligence, Emerging Opportunities"  report to their ... has announced the addition of the  ...
(Date:11/26/2015)... 2015 ) ... "Radioimmunoassay Market by Type (Reagents & Kits, ... Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), ... report to their offering. --> ... of the "Radioimmunoassay Market by Type ...
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... The men ... prominent nonprofit healthcare organizations in the country. They have overseen financial turnarounds, shown ... helped advance the healthcare industry as a whole through their advocacy and professional ...
(Date:11/27/2015)... ... ... Avid collector, Andrew Hawley from Vintage Rock Posters, announces his search for ... of Joplin's most famous and beautiful concert posters. The concert was held on March ... The According to Hawley, "It is hard to believe that Joplin's stardom was only ...
(Date:11/26/2015)... Marne, MI (PRWEB) , ... November 26, 2015 ... ... center for substance abuse located in central Michigan, have come together on Thanksgiving ... a specially produced video, available for viewing on the Serenity Point YouTube channel, ...
(Date:11/26/2015)... Cambridge, ON (PRWEB) , ... November 26, 2015 ... ... availability of a real-time eReferral system for diagnostic imaging in the Waterloo region. ... mammography, BMD and Nuclear Medicine tests directly from their electronic medical record (EMR) ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied ... the need to integrate dose form selection in early phase drug development. The ... organization supporting and bringing together the UK’s emerging life sciences companies, corporate partners, ...
Breaking Medicine News(10 mins):